推官网,引流量

直推官网引流,大量子站导流 效果持久显著

批量建站,提收录

形成站群推广模式 让搜索引擎大量收录!

提权重,树权威

实现权重提升 树立行业权威

部署快,自主可控

免费下载

省成本,提效率

多分站齐推广,性价比高 批量数据分析,帮助及时调整优化

关于OD
关于OD
特朗普访华,施展欧盟很愚蠢! 特朗普访华很得胜,但目下欧盟又尬在那了,因为他们还
关于OD
中新经纬5月18日电(董湘依)跟着好意思元体系里面实体经济的失衡,东说念主民币外
关于OD
开元棋牌官方网站入口 直播吧5月15日讯中超第12轮,北京国安主场4-2驯顺青岛
日前,国乒队员牛冠凯在酬酢平台告示喜信,晒出共创视频,与竹马之交的退役畅通员段冬
全球知谈,手机圈这两年的竞争还是到了尖锐化的进度,各家子品牌和性能线齐在拚命堆电
凡是稍稍可爱外出游玩的东说念主,齐不得不感喟我们国度的气候有多耐看。从东北漫天飞

OD资讯

ODZIXUN

OD资讯

查看更多
  • OD体育

    OD体育

  • 关于OD

    关于OD

  • OD资讯

    OD资讯

  • OD盘口

    OD盘口

OD盘口

  • OD盘口

OD体育(ODSports)官网入口

临床医学名词词典
首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
delivery combined with tuberculosis相关文献:
Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management.
Liebenberg D, Gordhan BG, Kana BD.
Front Cell Infect Microbiol. 2022 Sep 23;12:943545. doi: 10.3389/fcimb.2022.943545. eCollection 2022.
PMID:36211964
Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies.
Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, Nahid P.
PLoS Med. 2018 Jul 3;15(7):e1002595. doi: 10.1371/journal.pmed.1002595. eCollection 2018 Jul.
PMID:29969463
Enhanced tuberculosis clearance through the combination treatment with recombinant adenovirus-mediated granulysin delivery.
Hao L, Ma J, Shi C, Lin X, Zhang Y, Jo-Lewis BN, Lei Q, Ullah N, Yao Z, Fan X.
Theranostics. 2020 Aug 8;10(22):10046-10056. doi: 10.7150/thno.48052. eCollection 2020.
PMID:32929333
A Mouse Model for Tuberculosis Combined With Inhalable Imiquimod-PLGA Nanocomposite Particles Based on Macrophage Phenotype.
Nii T, Takizawa S, Akita T, Yamashita C, Takeuchi I, Makino K.
In Vivo. 2022 Sep-Oct;36(5):2166-2172. doi: 10.21873/invivo.12942.
PMID:36099123
Efficacy of Dual-Targeting Combined Anti-Tuberculosis Drug Delivery System in the Treatment of Tuberculous Meningitis.
Ma W, Peng H, Liu K, Wang Y, Wang W, Qu S, Li Y, Bi L, Zhang X, Zhang L.
J Biomed Nanotechnol. 2021 Oct 1;17(10):2034-2042. doi: 10.1166/jbn.2021.3169.
PMID:34706803
Clinical management of combined tuberculosis and diabetes.
van Crevel R, Koesoemadinata R, Hill PC, Harries AD.
Int J Tuberc Lung Dis. 2018 Dec 1;22(12):1404-1410. doi: 10.5588/ijtld.18.0340.
PMID:30606312
Tuberculosis disease among people with HIV: therapeutic advances.
Mave V, Paradkar M, Conradie F, Gupta A, Avihingsanon A, Meintjes G, Turkova A, Dooley KE, Chaisson RE.
Lancet HIV. 2025 May;12(5):e367-e381. doi: 10.1016/S2352-3018(25)00040-2. Epub 2025 Mar 24.
PMID:40147460
NIR-II AIE Luminogen-Based Erythrocyte-Like Nanoparticles with Granuloma-Targeting and Self-Oxygenation Characteristics for Combined Phototherapy of Tuberculosis.
Wang H, Li B, Sun Y, Ma Q, Feng Y, Jia Y, Wang W, Su M, Liu X, Shu B, Zheng J, Sang S, Yan Y, Wu Y, Zhang Y, Gao Q, Li P, Wang J, Ma F, Li X, Yan D, Wang D, Zou X, Liao Y.
Adv Mater. 2024 Sep;36(38):e2406143. doi: 10.1002/adma.202406143. Epub 2024 Jul 28.
PMID:39072892
Anti-tuberculosis site-specific oral delivery system that enhances rifampicin bioavailability in a fixed-dose combination with isoniazid.
Luciani-Giacobbe LC, Lorenzutti AM, Litterio NJ, Ramírez-Rigo MV, Olivera ME.
Drug Deliv Transl Res. 2021 Jun;11(3):894-908. doi: 10.1007/s13346-020-00847-9. Epub 2020 Sep 8.
PMID:32901368
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
Semitala FC, Kadota JL, Musinguzi A, Welishe F, Nakitende A, Akello L, Kunihira Tinka L, Nakimuli J, Ritar Kasidi J, Bishop O, Nakasendwa S, Baik Y, Patel D, Sammann A, Nahid P, Belknap R, Kamya MR, Handley MA, Phillips PP, Katahoire A, Berger CA, Kiwanuka N, Katamba A, Dowdy DW, Cattamanchi A.
PLoS Med. 2024 Feb 20;21(2):e1004356. doi: 10.1371/journal.pmed.1004356. eCollection 2024 Feb.
PMID:38377166
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3